These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23892209)

  • 61. Performance of Massachusetts Male Aging Study (MMAS) and androgen deficiency in the aging male (ADAM) questionnaires in the prediction of free testosterone in patients aged 40 years or older treated in outpatient regimen.
    Cabral RD; Busin L; Rosito TE; Koff WJ
    Aging Male; 2014 Sep; 17(3):147-54. PubMed ID: 24739016
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Is discontinuation of hormone replacement therapy possible for patients with late-onset hypogonadism?
    Tsujimura A; Takada S; Matsuoka Y; Hirai T; Takao T; Miyagawa Y; Nonomura N; Okuyama A
    Int J Urol; 2008 Jul; 15(7):625-9. PubMed ID: 18479356
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effects of some micronutrients on partial androgen deficiency in the aging male].
    He F; Feng L
    Zhonghua Nan Ke Xue; 2005 Oct; 11(10):784-6. PubMed ID: 16281517
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Testosterone therapy in the aging male.
    Lunenfeld B; Nieschlag E
    Aging Male; 2007 Sep; 10(3):139-53. PubMed ID: 17701658
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Androgen deficiency in older men: indications, advantages, and pitfalls of testosterone replacement therapy.
    McGill JJ; Shoskes DA; Sabanegh ES
    Cleve Clin J Med; 2012 Nov; 79(11):797-806. PubMed ID: 23125330
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Risks and benefits: new concepts of treatment of late-onset hypogonadism].
    Shang XJ; Huang YF
    Zhonghua Nan Ke Xue; 2014 Jun; 20(6):483-9. PubMed ID: 25029850
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oral testosterone replacement in Korean patients with PADAM.
    Hong JH; Ahn TY
    Aging Male; 2002 Mar; 5(1):52-6. PubMed ID: 12040976
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Male climacteric syndrome (andropause)].
    Guo Y; Li H
    Zhonghua Nan Ke Xue; 2004 Aug; 10(8):563-6. PubMed ID: 15362514
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Investigation, treatment and surveillance of late-onset hypogonadism in males: the official guidelines of the International Society for the Study of the Aging Male (ISSAM) with comments].
    Cuzin B; Giuliano F; Jamin C; Legros JJ; Lejeune H; Rigot JM; Roger M;
    Prog Urol; 2004 Feb; 14(1):1-14. PubMed ID: 15098744
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of questionnaires used for screening and symptom identification in hypogonadal men.
    Bernie AM; Scovell JM; Ramasamy R
    Aging Male; 2014 Dec; 17(4):195-8. PubMed ID: 25247629
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Change in testosterone concentrations over time is a better predictor than the actual concentrations for symptoms of late onset hypogonadism.
    Holm AC; Fredrikson MG; Theodorsson E; Palmefors LG; Karlsson PS; Joborn C; Hammar ML
    Aging Male; 2011 Dec; 14(4):249-56. PubMed ID: 21627562
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Investigation, treatment and monitoring of late-onset hypogonadism in males.
    Nieschlag E; Swerdloff R; Behre HM; Gooren LJ; Kaufman JM; Legros JJ; Lunenfeld B; Morley JE; Schulman C; Wang C; Weidner W; Wu FC
    Aging Male; 2005 Jun; 8(2):56-8. PubMed ID: 16096159
    [No Abstract]   [Full Text] [Related]  

  • 73. [Symptomatic evaluation of late onset hypogonadism in healthy Chinese men].
    Li JY; Li XY; Li M; Zhang GK; Ma FL; Liu ZM; Zhang NY; Meng P
    Zhonghua Nan Ke Xue; 2007 Apr; 13(4):320-3. PubMed ID: 17491264
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparing calculated free testosterone with total testosterone for screening and diagnosing late-onset hypogonadism in aged males: A cross-sectional study.
    Liu Z; Liu J; Shi X; Wang L; Yang Y; Tao M; Fu Q
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27714896
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevalence of Late-Onset Hypogonadism in Men with Localized and Metastatic Renal Cell Carcinoma.
    Ralla B; Magheli A; Wolff I; Erber B; Goranova I; Friedersdorff F; Hinz S; Kempkensteffen C; Miller K; Busch J
    Urol Int; 2017; 98(2):191-197. PubMed ID: 27732978
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The influence of partial androgen deficiency of aging men (PADAM) on the impulse regime of incretion of several hormones and mitotic activity].
    Pecherskiĭ AV; Semiglazov VF; Loran OB; Karpishchenko AI; Pecherskiĭ VI; Mazurov VI
    Tsitologiia; 2006; 48(10):862-6. PubMed ID: 17162845
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Late-onset hypogonadism and lifestyle-related metabolic disorders.
    Braga PC; Pereira SC; Ribeiro JC; Sousa M; Monteiro MP; Oliveira PF; Alves MG
    Andrology; 2020 Nov; 8(6):1530-1538. PubMed ID: 31991053
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Epidemiological Characteristics of Late-Onset Hypogonadism in Chinese Middle-Aged and Elderly Men: Two Cross-Sectional Studies in the Same Community.
    Zhou SJ; Zhao MJ; Yang YH; Guan D; Li ZG; Ji YD; Zhang BL; Shang XJ; Xiong CL; Gu YQ
    Am J Mens Health; 2020; 14(6):1557988320977991. PubMed ID: 33305661
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Physiological and clinical characteristics of andropause.
    Delev DP; Kostadinova II; Kostadinov ID; Ubenova DK
    Folia Med (Plovdiv); 2009; 51(1):15-22. PubMed ID: 19437894
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Role of androgen in the elderly. Exercise and androgens].
    Eto M
    Clin Calcium; 2013 Aug; 23(8):1191-6. PubMed ID: 23892221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.